ProPhase Labs Inc (PRPH)
4.44
+0.08
(+1.83%)
USD |
NASDAQ |
Sep 29, 16:00
4.41
-0.03
(-0.68%)
After-Hours: 20:00
ProPhase Labs Cash from Financing (TTM): -10.99M for June 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
June 30, 2023 | -10.99M |
March 31, 2023 | -17.12M |
December 31, 2022 | -26.02M |
September 30, 2022 | -17.49M |
June 30, 2022 | -14.36M |
March 31, 2022 | -12.73M |
December 31, 2021 | 35.13M |
September 30, 2021 | 36.16M |
June 30, 2021 | 46.08M |
March 31, 2021 | 50.62M |
December 31, 2020 | 9.99M |
September 30, 2020 | 7.031M |
June 30, 2020 | -2.893M |
March 31, 2020 | -2.893M |
December 31, 2019 | -5.822M |
September 30, 2019 | -2.929M |
June 30, 2019 | -2.929M |
March 31, 2019 | -14.29M |
December 31, 2018 | -11.36M |
September 30, 2018 | -15.19M |
June 30, 2018 | -24.38M |
March 31, 2018 | -14.77M |
December 31, 2017 | -16.20M |
September 30, 2017 | -12.48M |
June 30, 2017 | -3.287M |
Date | Value |
---|---|
March 31, 2017 | -1.531M |
December 31, 2016 | -0.10M |
September 30, 2016 | 1.38M |
June 30, 2016 | 2.42M |
March 31, 2016 | 2.944M |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 4.81M |
September 30, 2014 | 5.058M |
June 30, 2014 | 5.002M |
March 31, 2014 | 1.123M |
December 31, 2013 | 0.371M |
September 30, 2013 | 1.292M |
June 30, 2013 | 1.265M |
March 31, 2013 | 1.265M |
December 31, 2012 | 1.07M |
September 30, 2012 | 0.00 |
June 30, 2012 | -0.449M |
March 31, 2012 | -0.449M |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-26.02M
Minimum
Dec 2022
50.62M
Maximum
Mar 2021
2.272M
Average
-2.929M
Median
Jun 2019
Cash from Financing (TTM) Benchmarks
OncoCyte Corp | 11.62M |
Fonar Corp | -7.572M |
XWELL Inc | -10.99M |
Applied DNA Sciences Inc | -- |
Exagen Inc | -10.50M |